KRAS and neoplasm: Most articles about tumor heterogeneity have focused on common mutations such as KRAS, TP53, and PIK3CA while few data are available regarding MSI or MMR IHC tests and intra- and inter-tumoral heterogeneity, and its possible variations during the tumor growth process.